• Publications
  • Influence
Idarucizumab for dabigatran reversal
Economic Burden Associated With Parkinson Disease
The objective of this study was to estimate the annual cost burden of Parkinson disease (PD) in the United States. Resource use and cost profiles were developed using all-payer statewide hospitalExpand
Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study.
BACKGROUND H(1)-antihistamines are widely used for symptom relief in allergic disorders in infants and children; however, there are few prospective, randomized, double-blind, controlled studies ofExpand
Building a sense of community
While academe is working toward training people to work in an environment of interdisciplinary teamwork, what is needed is a shift in our sense of community in the workplace, a broadening of ourExpand
Treatment of rheumatoid arthritis: A review of recommendations and emerging therapy
The etiology of rheumatoid arthritis is not fully understood, but environmental and genetic factors have been proposed as potential theories. Genetic predisposition results in the destructive natureExpand
Dual therapy strategies for COPD: The scientific rationale for LAMA & LABA
There is a growing group of LAMA/LABA combination therapies in development. Investigations into the risks and benefits of LAMA/LABA therapy have demonstrated benefits.
Comparing Grade 4 Neutropenia Associated with Pegfilgrastim Administered via the Onpro Device versus Manual Injection with a Prefilled Syringe
www.JHOPonline.com l Journal of Hematology Oncology Pharmacy Vol 8 | No 3 l September 2018 Pegfilgrastim is a granulocyte colony-stimulating factor (G-CSF) used to promote the growth of white bloodExpand